This podcast provides a comprehensive guide to diagnosing and managing cardiac dysrhythmias within a surgical intensive care unit. It highlights that postoperative patients are at a higher risk for heart rhythm disturbances due to factors like electrolyte imbalances, surgery-induced stress, and preexisting comorbidities. The authors categorize these conditions into slow heart rates (bradyarrhythmias) and fast heart rates (tachyarrhythmias), detailing specific protocols for common issues such as atrial fibrillation and ventricular tachycardia. Management strategies range from pharmacological interventions and correcting metabolic triggers to emergency electrical cardioversion or pacemaker placement. Ultimately, the source emphasizes that accurate rhythm classification and stabilizing the patient’s hemodynamic state are the primary goals for critical care providers.
The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns.
Comprehensive Study Guide: Cardiac Dysrhythmias in the Surgical Intensive Care Unit
This study guide provides a detailed synthesis of the diagnosis, classification, and management of cardiac dysrhythmias within the surgical intensive care unit (SICU) environment.
Fundamentals of Dysrhythmia in the SICU
Cardiac dysrhythmias are common in the postoperative setting, with incidences ranging from 9% in noncardiac surgical patients to over 40% in cardiac surgery patients. Approximately 20% of all intensive care unit (ICU) patients experience significant dysrhythmias during their stay.
Common Etiologies
Dysrhythmias in the SICU are often precipitated by:
Hypoxia and acute respiratory failure.Myocardial ischemia.Catecholamine excess (endogenous or from vasopressor support).Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia).Routine medications or drug toxicity.Metabolic disturbances and acid-base imbalances.Diagnosis and Initial Assessment
Diagnosis relies on a focused physical examination and a standard 12-lead electrocardiogram (ECG). Clinicians must also observe the patient's response to specific maneuvers (like carotid massage) or drug therapies (like adenosine). Management is dictated by:
Patient Stability: Determining if the patient is hemodynamically stable or requires urgent intervention like cardioversion.Classification: Identifying the rhythm’s origin (atrial vs. ventricular).Mechanism: Understanding if the rhythm is caused by abnormal automaticity, triggered activity, or reentry.General Risk Factors
Patient Demographics: Advanced age, obesity, and metabolic syndrome.Medical History: Preexisting cardiac or pulmonary disease, hypertension, diabetes, and higher New York Heart Association (NYHA) classification.Surgical Factors: Type of surgery (e.g., valve replacements combined with CABG have higher rates than CABG alone), positive fluid balance during surgery, and complicated weaning from cardiopulmonary bypass.Markers of Illness: Dysrhythmias are often associated with longer ICU stays and may serve as markers for underlying critical illness.--------------------------------------------------------------------------------
Bradyarrhythmias
Bradyarrhythmias account for approximately 10% of ICU dysrhythmias. They originate from either the sinoatrial (SA) node or the atrioventricular (AV) node.
Sinoatrial (SA) Node Dysfunction
The SA node is the heart’s natural pacemaker. Dysfunction results from impulse generation failure or conduction failure.
Sinus Bradycardia: A heart rate below 60 bpm. It is considered pathologic only if symptomatic (syncope, chest pain) or if the heart rate fails to increase appropriately during activity.Sinus Pause or Arrest: The SA node transiently fails to fire.Sinus Exit Block: The SA node fires, but the impulse fails to propagate to the atria.Tachycardia-Bradycardia Syndrome: Characterized by alternating fast and slow rhythms. Management is difficult because treating one state often exacerbates the other, frequently requiring a permanent pacemaker combined with pharmacotherapy.Management of SA Node Dysfunction:
Identify and correct extrinsic causes (e.g., hypervagal tone, beta blockers, calcium channel antagonists, lithium).Acute Treatment: Atropine or beta-agonists for hemodynamic instability.Pacing: Transcutaneous pacing (short-term) or transvenous pacing as a bridge to a permanent device.Atrioventricular (AV) Node Dysfunction
AV blocks are classified by the severity of the conduction delay between the atria and ventricles.
First-Degree AV Block: Prolonged PR interval (greater than 210 ms).Second-Degree AV Block (Mobitz Type I/Wenckebach): Progressive PR interval prolongation until a QRS complex is "dropped." The PR interval shortens immediately after the dropped beat. This is usually nodal.Second-Degree AV Block (Mobitz Type II): Intermittent dropped QRS complexes without PR prolongation. This is "infranodal" (His-Purkinje system) and has a high risk of progressing to complete heart block.Third-Degree (Complete) Heart Block: Total AV dissociation. The ventricles rely on an innate escape rhythm (typically 40–50 bpm with a wide QRS).Management of AV Block:
Pharmacotherapy: Atropine and isoproterenol (though isoproterenol should be avoided in ischemic heart disease).Pacing: Permanent pacing is typically required for Mobitz Type II and third-degree blocks. Dopamine or epinephrine may be used as a bridge to pacing.--------------------------------------------------------------------------------
Tachyarrhythmias: Mechanisms and Classification
Tachyarrhythmias are broadly classified by their origin relative to the AV node, appearing as either narrow-complex (supraventricular) or wide-complex (ventricular) on an ECG.
Primary Mechanisms
Abnormal Automaticity: Cells outside the normal conduction system fire spontaneously.Triggered Activity: Occurs during "afterdepolarization," where the membrane potential reaches a threshold prematurely.Reentry: The most common mechanism; an impulse travels down two pathways with different conduction speeds and a unidirectional block, creating a self-propagating circuit.Supraventricular Tachyarrhythmias (SVT)
Sinus Tachycardia: Often a physiologic reflex to fever, hypovolemia, or anemia. The priority is treating the underlying cause rather than blunting the heart rate.Paroxysmal SVT (AVNRT & AVRT):AVNRT: Reentry within the AV node; usually narrow-complex with no visible P waves.AVRT: Involves an accessory pathway. "Orthodromic" is narrow-complex; "Antidromal" is wide-complex.Management: Adenosine is the first-line drug. Vagal maneuvers, beta blockers, or calcium channel blockers are alternatives.Wolff-Parkinson-White (WPW) Syndrome: Involves the Bundle of Kent (accessory pathway), often showing a "delta wave." Crucial Warning: Calcium channel blockers and digoxin are contraindicated as they can enhance accessory pathway conduction and lead to VF.Multifocal Atrial Tachycardia (MAT): Identified by three or more different P-wave morphologies. Common in chronic respiratory disease. Treatment focuses on the underlying pulmonary condition.Atrial Flutter: A reentrant circuit producing a "sawtooth" pattern, often at an atrial rate of 250–350 bpm (ventricular rate often 150 bpm). Treated with rate control or electrical cardioversion (50 J).Atrial Fibrillation (AF)
AF is the most common SVT in the ICU, characterized by an "irregularly irregular" rhythm and absent P waves.
Consequences: Loss of atrial kick (leading to hypotension/heart failure) and risk of mural thrombus/embolic stroke.Management Goals: Ventricular rate control, rhythm restoration, and emboli prevention.Rate vs. Rhythm Control: The AFFIRM study showed no long-term outcome difference between the two strategies in high-risk elderly patients. Beta blockers are first-line for rate control. Amiodarone is preferred if the ejection fraction is <40%.Cardioversion: Biphasic energy of 120–200 J is used for unstable patients. If AF lasts >48 hours, anticoagulation is required for 3 weeks before and 4 weeks after cardioversion to prevent stroke.Anticoagulation: The AUGUSTUS trial suggested apixaban plus a P2Y12 inhibitor results in less bleeding than warfarin-based regimens for patients requiring PCI.--------------------------------------------------------------------------------
Ventricular Tachyarrhythmias
These rhythms are generally more life-threatening and often associated with structural heart disease or postoperative ischemia.
Premature Ventricular Contractions (PVCs)
Commonly caused by electrolyte imbalances or catecholamine excess. In asymptomatic patients without structural heart disease, they rarely require treatment. In patients with low ejection fractions, they may precede malignant rhythms.
Monomorphic Ventricular Tachycardia (VT)
Presents as a wide QRS complex with a uniform appearance.
Nonsustained: Lasts <30 seconds.Sustained: Usually caused by a reentry circuit around a healed MI scar.Management: Synchronized cardioversion (100 J) for unstable patients. Stable patients may receive procainamide, sotalol, or amiodarone.Polymorphic Ventricular Tachycardia and Torsades de Pointes
Polymorphic VT: Irregular, undulating appearance; often caused by acute ischemia. Requires prompt cardioversion.Torsades de Pointes: A specific polymorphic VT associated with a prolonged QT interval (>460 ms). It appears to "twist" around the baseline.Causes: Hypokalemia, hypomagnesemia, and various drugs (Class I/III antiarrhythmics, haloperidol, certain antibiotics).Management: Identification and removal of offending agents, magnesium administration, and potentially overdrive pacing. Do not use QT-prolonging antiarrhythmics.--------------------------------------------------------------------------------
Glossary of Key Terms
Adenosine: An extremely short-acting drug used to slow AV node conduction, primarily for diagnosing or terminating reentry SVTs.Automaticity: The ability of cardiac cells to spontaneously generate an electrical impulse.Bundle of Kent: The accessory conduction pathway associated with Wolff-Parkinson-White syndrome.Cardioversion: The delivery of a synchronized electrical shock to restore a normal heart rhythm.Delta Wave: A slurred upstroke of the QRS complex indicating preexcitation, characteristic of WPW syndrome.Infranodal: Originating below the AV node, specifically within the His-Purkinje system.Orthodromic Tachycardia: A rhythm where the impulse travels antegrade through the AV node and retrograde through an accessory pathway.Proarrhythmic: The potential for an antiarrhythmic drug to actually cause or worsen a dysrhythmia.Reentry: A circular electrical circuit within the heart tissue that becomes a self-propagating focus for tachycardia.Sick Sinus Syndrome: An older term for a range of SA node dysfunctions, including bradycardia and sinus arrest.Torsades de Pointes: A "twisting" polymorphic ventricular tachycardia occurring in the setting of a prolonged QT interval.Vagal Tone: The effect of the vagus nerve on the heart, which slows the heart rate and AV conduction.